Dyne Therapeutics

Dyne is developing treatments for serious muscle diseases, starting with myotonic dystrophy type 1 (DM1).

DYNE-101 an investigational therapeutic for people living with myotonic dystrophy type 1 (DM1) DYNE-101 is an investigational therapeutic being evaluated

DYNE-302 a product candidate for people living with facioscapulohumeral muscular dystrophy (FSHD) DYNE-302 is Dyne’s product candidate being developed for

Dyne outlines its long-term commitment to engaging with the Myotonic and Duchenne Muscular Dystrophy communities in a February 2024 letter.

Meet Ravi “I want to be someone:”Ravi’s journey with DMD Ravi has something to say. A law school student, Ravi is naturally soft-spoken. But with every

Loraine Dressler anchors her family’s fight against myotonic dystrophy—while undergoing the same battle herself. The doctor met Loraine and her daughter,

Our focus: Letters to our communities July 28, 2026 Dear FSHD Community: Today, we are pleased to share that we have received clearance from the U.S. Food

scientific publications & presentations September 29 – October 2, 2026American Association of Neuromuscular & Electrodiagnostic Medicine Long-Term

Dyne aims to advance nucleic acid-based therapeutics by leveraging its expertise in human biology for precision medicine in rare diseases.

Dyne’s approach has great potential to address the underlying cause of many different neuromuscular diseases, and to develop transformative therapies that uniquely draw from the experience of people living with those diseases. I’m delighted to be part of the team furthering that important mission.

What drew me to Dyne was the company’s commitment to developing revolutionary therapies that target muscle tissue with unprecedented precision. It’s a joy to lead a research team with such unwavering dedication to transforming the lives of people and families living with serious muscle diseases.

The page describes the company’s goal to create life-changing therapies that address the root causes of diseases, not just symptoms.

Dyne was founded with a singular focus: To transform the lives of people with serious muscle diseases by creating the first muscle-targeted therapies.

corporate responsibility Dyne Therapeutics is a clinical-stage company focused on delivering functional improvement for people living with genetically

Repairing muscle, reclaiming now. Life-transforming therapies for inherited muscle diseases.